by Jody Ranck | June 06, 2022
How Not to Implement AI
Mistakes were made in the deployment of artificial intelligence in aircraft, leading to fatal outcomes. How can healthcare avoid similar results?
Tag Archive: FDA
by Jody Ranck | June 06, 2022
Mistakes were made in the deployment of artificial intelligence in aircraft, leading to fatal outcomes. How can healthcare avoid similar results?
by John Moore | December 15, 2021
Chilmark’s 2021 predictions were mostly accurate, but could have been more daring. Our outlook on 2022 is forthcoming and will include some tougher calls.
by John Moore | November 29, 2021
Unique circumstances have led to the rise of this evolving sector. Despite plenty of growth potential, the most effective approach remains to be seen.
by Jody Ranck | November 16, 2021
The FDA released a set of principles for the implementation of new technologies, but will it be enough to positively impact current industry practice?
by Jody Ranck | April 12, 2021
Digital twins provide more dynamic models than conventional simulations and will provide valuable tools for precision medicine. Learn more in this deep dive article.
by Chilmark Team | December 18, 2020
Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s […]
by Jody Ranck | October 15, 2020
While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare.
by Alex Lennox-Miller | January 30, 2020
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]
John Moore · 3 weeks ago
Colin Rogers · 2 months ago
John Moore III · 2 months ago